Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $269.77B.
ENTERPRISE VALUE (EV)
$269.77B
AstraZeneca PLC
Market Cap
$247.58B
Enterprise Value (EV)
$269.77B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AstraZeneca PLC (AZN) | $247.58B | $269.77B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.15B | $262.64B |
| Amgen Inc. (AMGN)vs › | $206.42B | $249.74B |
| Novo Nordisk A/S (NVO)vs › | $195.43B | $210.01B |
| Gilead Sciences, Inc. (GILD)vs › | $179.79B | $202.86B |
| Abbott Laboratories (ABT)vs › | $178.87B | $206.37B |
| Pfizer Inc. (PFE)vs › | $157.59B | $219.81B |
| Roche Holding AG (RHHBY)vs › | $339.06B | $371.56B |
| UnitedHealth Group Incorporated (UNH)vs › | $352.61B | $397.36B |
| Danaher Corporation (DHR)vs › | $141.00B | $163.21B |
Market Cap
$247.58B
Total Debt
$27.90B
Cash
$5.71B
Enterprise Value
$269.77B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
